US › Healthcare

Hyperion DeFi, Inc. (HYPD)

US · Healthcare · Biotechnology

$3.47+6.12%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$357,693

Net profit

$31.0M

EPS

$0.92

EPS estimate

$2.24

Net margin

8,652.9%

EPS came in at 0.92 against a street estimate of 2.24 — a miss of 58.9%.

Key statistics

Market cap

$54.2M

Forward P/E

0.0

P/B

0.53

Book value

$6.66

EPS (TTM)

$-3.86

52-week high

$13.71

52-week low

$2.34

50-day MA

$2.96

200-day MA

$3.40

Beta

2.53

Analyst view

with an average price target of $9.82.

Shareholding

Insiders

13.49%

Institutions

18.00%

Largest institutional holders

Fund	Stake
Arrington Capital Management, LLC	1.92%
Morgan Stanley - Brokerage Accounts	1.53%
Redwood Wealth Management Group LLC	1.18%
Almanack Investment Partners, LLC.	1.09%
Jane Street Group LLC	0.83%
Renaissance Technologies Corp	0.74%
Vanguard Capital Management, LLC	0.54%
BlackRock Inc	0.52%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Hyperion DeFi, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.